Treatment of duodenal ulcers: An update

F. Castiglione, B. Daniele, S. Pignata, A. Sarubbi, G. Mazzacca

Research output: Contribution to journalArticlepeer-review


Aim: To assess current practice in duodenal ulcer therapy. Method: Survey of recent studies. Inhibition of acid secretion: Profound and long-lasting inhibition of acid secretion can be obtained with proton pump-inhibiting drugs while a temporary suppression of gastric secretion can be obtained with the H2-receptor antagonists. There are both advantages and disadvantages in pronounced acid inhibition in the short- and long-term treatment of duodenal ulcers, particularly with regard to long-term safety. Need to eradicate Helicobacter pylori: The contribution made by H. pylori to the etiology and pathogenesis of duodenal ulcers needs further clarification, but it seems clear that eradication of the organism dramatically reduces the ulcer relapse rate. There is no general agreement about the drugs required to eradicate this bacterium because a number of side effects have been reported and compliance may be low.

Original languageEnglish
JournalEuropean Journal of Gastroenterology and Hepatology
Issue numberSUPPL. 2
Publication statusPublished - 1993


  • Duodenal ulcer
  • Helicobacter pylori

ASJC Scopus subject areas

  • Gastroenterology


Dive into the research topics of 'Treatment of duodenal ulcers: An update'. Together they form a unique fingerprint.

Cite this